Healthcare provider profile · identity verified

Donna Lawlor, MD

Family Practice · ELKADER, IA · NPI 1669405528

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	506	109
Furosemide	Furosemide	311	65
Lisinopril	Lisinopril	278	66
Levothyroxine Sodium	Levothyroxine Sodium	253	46
Potassium Chloride	Potassium Chloride	252	40
Amlodipine Besylate	Amlodipine Besylate	213	48
Omeprazole	Omeprazole	212	48
Gabapentin	Gabapentin	195	32
Hydrochlorothiazide	Hydrochlorothiazide	187	46
Metoprolol Succinate	Metoprolol Succinate	179	41
Metoprolol Tartrate	Metoprolol Tartrate	171	40
Metformin Hcl	Metformin Hcl	158	31
Eliquis	Apixaban	156	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	39
Rosuvastatin Calcium	Rosuvastatin Calcium	125	29
Alprazolam	Alprazolam	122	29
Clopidogrel	Clopidogrel Bisulfate	109	21
Tamsulosin Hcl	Tamsulosin Hcl	108	30
Simvastatin	Simvastatin	107	21
Prednisone	Prednisone	106	48
Sertraline Hcl	Sertraline Hcl	106	15
Carvedilol	Carvedilol	105	18
Allopurinol	Allopurinol	98	25
Donepezil Hcl	Donepezil Hcl	95	13
Alendronate Sodium	Alendronate Sodium	94	18
Fluoxetine Hcl	Fluoxetine Hcl	94	19
Warfarin Sodium	Warfarin Sodium	91	18
Pantoprazole Sodium	Pantoprazole Sodium	87	18
Losartan Potassium	Losartan Potassium	83	21
Tramadol Hcl	Tramadol Hcl	83	12
Trazodone Hcl	Trazodone Hcl	83	17
Lorazepam	Lorazepam	75	15
Spironolactone	Spironolactone	75	16
Doxazosin Mesylate	Doxazosin Mesylate	70	13
Duloxetine Hcl	Duloxetine Hcl	69	13
Atenolol	Atenolol	67	12
Glimepiride	Glimepiride	67	12
Myrbetriq	Mirabegron	67	suppressed
Cephalexin	Cephalexin	65	32
Meloxicam	Meloxicam	64	20
Famotidine	Famotidine	63	11
Pioglitazone Hcl	Pioglitazone Hcl	59	12
Ramipril	Ramipril	57	suppressed
Metformin Hcl Er	Metformin Hcl	53	suppressed
Diazepam	Diazepam	51	suppressed
Fluticasone Propionate	Fluticasone Propionate	51	15
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	49	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	12
Finasteride	Finasteride	47	14
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Mirtazapine	Mirtazapine	45	suppressed
Amoxicillin	Amoxicillin	44	38
Escitalopram Oxalate	Escitalopram Oxalate	44	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	44	14
Haloperidol	Haloperidol	43	suppressed
Xarelto	Rivaroxaban	43	suppressed
Nystatin	Nystatin	42	19
Oxycodone Hcl	Oxycodone Hcl	42	16
Montelukast Sodium	Montelukast Sodium	40	suppressed
Ondansetron Hcl	Ondansetron Hcl	40	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	35
Doxycycline Hyclate	Doxycycline Hyclate	39	22
Pravastatin Sodium	Pravastatin Sodium	39	suppressed
Pregabalin	Pregabalin	39	12
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Azithromycin	Azithromycin	35	29
Buspirone Hcl	Buspirone Hcl	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	24
Propranolol Hcl	Propranolol Hcl	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Bumetanide	Bumetanide	31	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Glipizide	Glipizide	25	suppressed
Latanoprost	Latanoprost	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	suppressed
Tresiba Flextouch U-200	Insulin Degludec	22	suppressed
Valsartan	Valsartan	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Baclofen	Baclofen	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Tiadylt Er	Diltiazem Hcl	21	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	20	20
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	11
Nifedipine Er	Nifedipine	20	suppressed
Timolol Maleate	Timolol Maleate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Nabumetone	Nabumetone	19	suppressed
Ozempic	Semaglutide	19	suppressed
Phenobarbital	Phenobarbital	19	suppressed
Topiramate	Topiramate	19	suppressed
Fentanyl	Fentanyl	18	suppressed
Triazolam	Triazolam	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Caplyta	Lumateperone Tosylate	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Naproxen	Naproxen	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Bacitracin-Polymyxin	Bacitracin/Polymyxin B Sulfate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Fenofibrate	Fenofibrate	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Vraylar	Cariprazine Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Xcopri	Cenobamate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azathioprine	Azathioprine	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error